Cargando…

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review

Endothelial injury and microvascular/macrovascular thrombosis are common pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regimens remain unknown across the spectrum of illness severity of COVID-19. A variety of antithrombotic agents, doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Talasaz, Azita H., Sadeghipour, Parham, Kakavand, Hessam, Aghakouchakzadeh, Maryam, Kordzadeh-Kermani, Elaheh, Van Tassell, Benjamin W., Gheymati, Azin, Ariannejad, Hamid, Hosseini, Seyed Hossein, Jamalkhani, Sepehr, Sholzberg, Michelle, Monreal, Manuel, Jimenez, David, Piazza, Gregory, Parikh, Sahil A., Kirtane, Ajay J., Eikelboom, John W., Connors, Jean M., Hunt, Beverley J., Konstantinides, Stavros V., Cushman, Mary, Weitz, Jeffrey I., Stone, Gregg W., Krumholz, Harlan M., Lip, Gregory Y.H., Goldhaber, Samuel Z., Bikdeli, Behnood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American College of Cardiology Foundation. Published by Elsevier. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963001/
https://www.ncbi.nlm.nih.gov/pubmed/33741176
http://dx.doi.org/10.1016/j.jacc.2021.02.035
_version_ 1783665558798991360
author Talasaz, Azita H.
Sadeghipour, Parham
Kakavand, Hessam
Aghakouchakzadeh, Maryam
Kordzadeh-Kermani, Elaheh
Van Tassell, Benjamin W.
Gheymati, Azin
Ariannejad, Hamid
Hosseini, Seyed Hossein
Jamalkhani, Sepehr
Sholzberg, Michelle
Monreal, Manuel
Jimenez, David
Piazza, Gregory
Parikh, Sahil A.
Kirtane, Ajay J.
Eikelboom, John W.
Connors, Jean M.
Hunt, Beverley J.
Konstantinides, Stavros V.
Cushman, Mary
Weitz, Jeffrey I.
Stone, Gregg W.
Krumholz, Harlan M.
Lip, Gregory Y.H.
Goldhaber, Samuel Z.
Bikdeli, Behnood
author_facet Talasaz, Azita H.
Sadeghipour, Parham
Kakavand, Hessam
Aghakouchakzadeh, Maryam
Kordzadeh-Kermani, Elaheh
Van Tassell, Benjamin W.
Gheymati, Azin
Ariannejad, Hamid
Hosseini, Seyed Hossein
Jamalkhani, Sepehr
Sholzberg, Michelle
Monreal, Manuel
Jimenez, David
Piazza, Gregory
Parikh, Sahil A.
Kirtane, Ajay J.
Eikelboom, John W.
Connors, Jean M.
Hunt, Beverley J.
Konstantinides, Stavros V.
Cushman, Mary
Weitz, Jeffrey I.
Stone, Gregg W.
Krumholz, Harlan M.
Lip, Gregory Y.H.
Goldhaber, Samuel Z.
Bikdeli, Behnood
author_sort Talasaz, Azita H.
collection PubMed
description Endothelial injury and microvascular/macrovascular thrombosis are common pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regimens remain unknown across the spectrum of illness severity of COVID-19. A variety of antithrombotic agents, doses, and durations of therapy are being assessed in ongoing randomized controlled trials (RCTs) that focus on outpatients, hospitalized patients in medical wards, and patients critically ill with COVID-19. This paper provides a perspective of the ongoing or completed RCTs related to antithrombotic strategies used in COVID-19, the opportunities and challenges for the clinical trial enterprise, and areas of existing knowledge, as well as data gaps that may motivate the design of future RCTs.
format Online
Article
Text
id pubmed-7963001
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher by the American College of Cardiology Foundation. Published by Elsevier.
record_format MEDLINE/PubMed
spelling pubmed-79630012021-03-17 Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review Talasaz, Azita H. Sadeghipour, Parham Kakavand, Hessam Aghakouchakzadeh, Maryam Kordzadeh-Kermani, Elaheh Van Tassell, Benjamin W. Gheymati, Azin Ariannejad, Hamid Hosseini, Seyed Hossein Jamalkhani, Sepehr Sholzberg, Michelle Monreal, Manuel Jimenez, David Piazza, Gregory Parikh, Sahil A. Kirtane, Ajay J. Eikelboom, John W. Connors, Jean M. Hunt, Beverley J. Konstantinides, Stavros V. Cushman, Mary Weitz, Jeffrey I. Stone, Gregg W. Krumholz, Harlan M. Lip, Gregory Y.H. Goldhaber, Samuel Z. Bikdeli, Behnood J Am Coll Cardiol The Present and Future Endothelial injury and microvascular/macrovascular thrombosis are common pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal thromboprophylactic regimens remain unknown across the spectrum of illness severity of COVID-19. A variety of antithrombotic agents, doses, and durations of therapy are being assessed in ongoing randomized controlled trials (RCTs) that focus on outpatients, hospitalized patients in medical wards, and patients critically ill with COVID-19. This paper provides a perspective of the ongoing or completed RCTs related to antithrombotic strategies used in COVID-19, the opportunities and challenges for the clinical trial enterprise, and areas of existing knowledge, as well as data gaps that may motivate the design of future RCTs. by the American College of Cardiology Foundation. Published by Elsevier. 2021-04-20 2021-03-16 /pmc/articles/PMC7963001/ /pubmed/33741176 http://dx.doi.org/10.1016/j.jacc.2021.02.035 Text en © 2021 by the American College of Cardiology Foundation. Published by Elsevier. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle The Present and Future
Talasaz, Azita H.
Sadeghipour, Parham
Kakavand, Hessam
Aghakouchakzadeh, Maryam
Kordzadeh-Kermani, Elaheh
Van Tassell, Benjamin W.
Gheymati, Azin
Ariannejad, Hamid
Hosseini, Seyed Hossein
Jamalkhani, Sepehr
Sholzberg, Michelle
Monreal, Manuel
Jimenez, David
Piazza, Gregory
Parikh, Sahil A.
Kirtane, Ajay J.
Eikelboom, John W.
Connors, Jean M.
Hunt, Beverley J.
Konstantinides, Stavros V.
Cushman, Mary
Weitz, Jeffrey I.
Stone, Gregg W.
Krumholz, Harlan M.
Lip, Gregory Y.H.
Goldhaber, Samuel Z.
Bikdeli, Behnood
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
title Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
title_full Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
title_fullStr Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
title_full_unstemmed Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
title_short Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
title_sort recent randomized trials of antithrombotic therapy for patients with covid-19: jacc state-of-the-art review
topic The Present and Future
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963001/
https://www.ncbi.nlm.nih.gov/pubmed/33741176
http://dx.doi.org/10.1016/j.jacc.2021.02.035
work_keys_str_mv AT talasazazitah recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT sadeghipourparham recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT kakavandhessam recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT aghakouchakzadehmaryam recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT kordzadehkermanielaheh recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT vantassellbenjaminw recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT gheymatiazin recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT ariannejadhamid recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT hosseiniseyedhossein recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT jamalkhanisepehr recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT sholzbergmichelle recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT monrealmanuel recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT jimenezdavid recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT piazzagregory recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT parikhsahila recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT kirtaneajayj recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT eikelboomjohnw recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT connorsjeanm recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT huntbeverleyj recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT konstantinidesstavrosv recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT cushmanmary recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT weitzjeffreyi recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT stonegreggw recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT krumholzharlanm recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT lipgregoryyh recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT goldhabersamuelz recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview
AT bikdelibehnood recentrandomizedtrialsofantithrombotictherapyforpatientswithcovid19jaccstateoftheartreview